Selective extraction of Cyclopia for enhanced in vitro phytoestrogenicity and benchmarking against commercial phytoestrogen extracts

Journal of Steroid Biochemistry and Molecular Biology

Volumn 112, Issue 1-3, 2008, Pages 74-86

  Mfenyana, Ciko ^a   DeBeer, Dalene ^b   Joubert, Elizabeth ^a,b   Louw, Ann ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b ARC INFRUITEC NIETVOORBIJ   (South Africa)

Author keywords

Alkaline phosphatase assay; Cyclopia; E screen; ERE containing promoter reporter assay; Nutraceutical; Phytoestrogens; Whole cell ER binding

Indexed keywords

ACETIC ACID ETHYL ESTER; ALKALINE PHOSPHATASE; CIMICIFUGA RACEMOSA EXTRACT; CYCLOPIA GENISTOIDES EXTRACT; CYCLOPIA SUBTERNATA EXTRACT; ESTROGEN RECEPTOR; FEMOLENE ULTRA; GLYCINE MAX EXTRACT; ISOFLAVONE DERIVATIVE; LUTEOLIN; METHANOL; PHYTOESTROGEN; PHYTOPAUSE FORTE; PLANT EXTRACT; POLYPHENOL; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYCLOPIA GENISTOIDES; CYCLOPIA SUBTERNATA; DRUG ACTIVITY; DRUG EFFICACY; DRUG ISOLATION; DRUG POTENCY; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEGUME; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; SOLVENT EXTRACTION;

CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOPIA PLANT; FLAVONOIDS; HUMANS; MASS SPECTROMETRY; PHENOLS; PHYTOESTROGENS; PLANT EXTRACTS; RECEPTORS, ESTROGEN;

CYCLOPIA GENISTOIDES; CYCLOPIA SUBTERNATA;

EID: 55349137705     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.08.005     Document Type: Article

References (67)

1. Rapkin A.J. Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment. Am. J. Obstet. Gynecol. 196 (2007) 97-106
2. Bhasin S., Enzlin P., Coviello A., and Basson R. Sexual dysfunction in men and women with endocrine disorders. Lancet 369 (2007) 597-611
3. Stepan J.J., Burr D.B., Pavo I., Sipos A., Michalska D., Li J., Fahrleitner-Pammer A., Petto H., Westmore M., Michalsky D., Sato M., and Dobnig H. Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis. Bone 41 (2007) 378-385
4. Casadesus G., Milliken E.L., Webber K.M., Bowen R.L., Lei Z., Rao C.V., Perry G., Keri R.A., and Smith M.A. Increases in luteinizing hormone are associated with declines in cognitive performance. Mol. Cell. Endocrinol. 269 (2007) 107-111
5. Badgio P.C., and Worden B.L. Cognitive functioning and aging in women. J. Women Aging 19 (2007) 13-30
6. Stefanick M.L., Anderson G.L., Margolis K.L., Hendrix S.L., Rodabough R.J., Paskett E.D., Lane D.S., Hubbell F.A., Assaf A.R., Sarto G.E., Schenken R.S., Yasmeen S., Lessin L., and Chlebowski R.T. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA 295 (2006) 1647-1657
7. Linet M.S. Invited commentary: postmenopausal unopposed estrogen and breast cancer risk in the women's health initiative-before and beyond. Am. J. Epidemiol. 167 (2008) 1416-1420
8. Salehi F., Dunfield L., Phillips K.P., Krewski D., and Vanderhyden B.C. Risk factors for ovarian cancer: an overview with emphasis on hormonal factors. J. Toxicol. Environ. Health B: Crit. Rev. 11 (2008) 301-321
9. Lewars M.D. Premature menopause: article's recommendation of HRT is highly questionable. BMJ 336 (2008) 1033-1034
10. Castelo-Branco C., Ferrer J., Palacios S., and Cornago S. The prescription of hormone replacement therapy in Spain: differences between general practitioners and gynaecologists. Maturitas 55 (2006) 308-316
11. Gebbie A. Hormone replacement therapy. Medicine 35 (2007) 529-532
12. Pardini D. Menopausal hormone therapy. Arq. Bras. Endocrinol. Metabol. 51 (2007) 938-942
13. Castelo-Branco C., Ferrer J., Palacios S., Cornago S., and Peralta S. Spanish post-menopausal women's viewpoints on hormone therapy. Maturitas 56 (2007) 420-428
14. Wathen C.N. Alternatives to hormone replacement therapy: a multi-method study of women's experiences. Complement. Ther. Med. 14 (2006) 185-192
15. Lotke P.S. Phytoestrogens: a potential role in hormone replacement therapy. Primary Care Update OB/GYNS 5 (1998) 290-295
16. Rice S., and Whitehead S.A. Phytoestrogens and breast cancer, promoters or protectors?. Endocr Relat. Cancer 13 (2006) 995-1015
17. Delmonte P., and Rader J.I. Analysis of isoflavones in foods and dietary supplements. J. AOAC Int. 89 (2006) 1138-1146
18. Power K.A., and Thompson L.U. Can the combination of flaxseed and its lignans with soy and its isoflavones reduce the growth stimulatory effect of soy and its isoflavones on established breast cancer?. Mol. Nutr. Food Res. 51 (2007) 845-856
19. Minich D.M., and Bland J.S. A review of the clinical efficacy and safety of cruciferous vegetable phytochemicals. Nutr. Rev. 65 (2007) 259-267
20. Vatanparast H., and Chilibeck P.D. Does the effect of soy phytoestrogens on bone in postmenopausal women depend on the equol-producing phenotype?. Nutr. Rev. 65 (2007) 294-299
21. Hertrampf T., Schmidt S., Laudenbach-Leschowsky U., Seibel J., and Diel P. Tissue-specific modulation of cyclooxygenase-2 (Cox-2) expression in the uterus and the v. cava by estrogens and phytoestrogens. Mol. Cell. Endocrinol. 243 (2005) 51-57
22. Brzezinski A., and Debi A. Phytoestrogens: the "natural" selective estrogen receptor modulators?. Eur. J. Obstet. Gynecol. Reprod. Biol. 85 (1999) 47-51
23. Lof M., and Weiderpass E. Epidemiologic evidence suggests that dietary phytoestrogen intake is associated with reduced risk of breast, endometrial, and prostate cancers. Nutr. Res. 26 (2006) 609-619
24. Radowicki S., Skorzewska K., Rudnicka E., Szlendak-Sauer K., and Wierzba W. Effectiveness and safety of the treatment of menopausal syndrome with Cimicifuga racemosa dry extract. Ginekol. Pol. 77 (2006) 678-683
25. Clarkson T.B., Anthony M.S., and Morgan T.M. Inhibition of postmenopausal atherosclerosis progression: a comparison of the effects of conjugated equine estrogens and soy phytoestrogens. J. Clin. Endocrinol. Metab. 86 (2001) 41-47
26. Panay N. Integrating phytoestrogens with prescription medicines-a conservative clinical approach to vasomotor symptom management. Maturitas 57 (2007) 90-94
27. Degen G.H., Janning P., Wittsiepe J., Upmeier A., and Bolt H.M. Integration of mechanistic data in the toxicological evaluation of endocrine modulators. Toxicol. Lett. 127 (2002) 225-237
28. Oldendick R., Coker A.L., Wieland D., Raymond J.I., Probst J.C., Schell B.J., and Stoskopf C.H. Population-based survey of complementary and alternative medicine usage, patient satisfaction, and physician involvement, South Carolina Complementary Medicine Program Baseline Research Team. South Med. J. 93 (2000) 375-381
29. du Toit J., Joubert E., and Britz T.J. Honeybush tea: a rediscovered indigenous South African herbal tea. J. Sustain Agr. 12 (1998) 67-84
30. Verhoog N.J.D., Joubert E., and Louw A. Screening of four Cyclopia (honeybush) species for putative phytoestrogenic activity through estrogen receptor binding assays. S. Afr. J. Sci. 103 (2007) 13-21
31. Singleton V.L., and Rossi Jr. J.A. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am. J. Enol. Vitic. 16 (1965) 144-158
32. Zhishen J., Mengcheng T., and Jianming W. The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals. Food Chem. 64 (1999) 555-559
33. Wilson V.S., Bobseine K., and Gray Jr. L.E. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists. Toxicol. Sci. 5 (2004) 180
34. Markiewicz L., Garey J., Adlercreutz H., and Gurpide E. In vitro bioassays of non-steroidal phytoestrogens. J. Steroid Biochem. Mol. Biol. 45 (1993) 399-405
35. Soto A.M., Maffini M.V., Schaeberle C.M., and Sonnenschein C. Strengths and weaknesses of in vitro assays for estrogenic and androgenic activity. Best Pract. Res. Clin. Endocrinol. Metab. 20 (2006) 15-33
36. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
37. Joubert E., Otto F., Grüner S., and Weinreich B. Reversed-phase HPLC determination of mangiferin, isomangiferin and hesperidin in Cyclopia and the effect of harvesting date on the phenolic composition of C. genistoides. Eur. Food Res. Technol. 216 (2003) 270-273
38. Cassidy A. Phytoestrogens and women's health. Women Health Med. 1 (2004) 30-33
39. Beck V., Rohr U., and Jungbauer A. Phytoestrogens derived from red clover: an alternative to estrogen replacement therapy?. J. Steroid Biochem. Mol. Biol. 94 (2005) 499-518
40. Verhoog N.J.D., Joubert E., and Louw A. Evaluation of the phytoestrogenic activity of Cyclopia genistoides (honeybush) methanol extracts and relevant polyphenols. J. Agric. Food Chem. 55 (2007) 4371-4381
41. Wober J., Wange I., and Vollmer G. Stimulation of alkaline phosphatase activity in Ishikawa cells induced by various phytoestrogens and synthetic estrogens. J. Steroid Biochem. Mol. Biol. 83 (2002) 227-233
42. De Naeyer A., Vanden Berghe W., Pocock V., Milligan S., Haegeman G., and De Keukeleire D. Estrogenic and anticarcinogenic properties of kurarinone, a lavandulyl flavanone from the roots of Sophora flavescens. J. Nat. Prod. 67 (2004) 1829-1832
43. Gutendorf B., and Westendorf J. Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens. Toxicology 166 (2001) 79-89
44. Zhang E.J., Ng K.M., and Luo K.Q. Extraction and purification of isoflavones from soybeans and characterization of their estrogenic activities. J. Agric. Food Chem. 55 (2007) 6940-6950
45. Cheng W.Y., Kuo Y.H., and Huang C.J. Isolation and identification of novel estrogenic compounds in yam tuber (Dioscorea alata). J. Agric. Food Chem. 55 (2007) 7350-7358
46. King M.L., Adler S.R., and Murphy L.L. Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation. Integr. Cancer Ther. 5 (2006) 236-243
47. Murphy P.A., Barua K., and Hauck C.C. Solvent extraction selection in the determination of isoflavones in soy foods. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 777 (2002) 129-138
48. Tsai H.S., Huang L.J., Lai Y.H., Chang J.C., Lee R.S., and Chiou R.Y. Solvent effects on extraction and HPLC analysis of soybean isoflavones and variations of isoflavone compositions as affected by crop season. J. Agric. Food Chem. 55 (2007) 7712-7715
49. Rostagno M.A., Palma M., and Barroso C.G. Ultrasound-assisted extraction of isoflavones from soy beverages blended with fruit juices. Anal. Chim. Acta 597 (2007) 265-272
50. Booth N.L., Overk C.R., Yao P., Totura S., Deng Y., Hedayat A.S., Bolton J.L., Pauli G.F., and Farnsworth N.R. Seasonal variation of red clover (Trifolium pratense L., Fabaceae) isoflavones and estrogenic activity. J. Agric. Food Chem. 54 (2006) 1277-1282
51. Ise R., Han D., Takahashi Y., Terasaka S., Inoue A., Tanji M., and Kiyama R. Expression profiling of the estrogen responsive genes in response to phytoestrogens using a customized DNA microarray. FEBS Lett. 579 (2005) 1732-1740
52. Ji Z.N., Zhao W.Y., Liao G.R., Choi R.C., Lo C.K., Dong T.T., and Tsim K.W. In vitro estrogenic activity of formononetin by two bioassay systems. Gynecol. Endocrinol. 22 (2006) 578-584
53. Ferreira D., Kamara B.I., Brandt E.V., and Joubert E. Phenolic compounds from Cyclopia intermedia (honeybush tea). J. Agric. Food Chem. 46 (1998) 3406-3410
54. Kamara B.I., Brand D.J., Brandt E.V., and Joubert E. Phenolic metabolites from honeybush tea (Cyclopia subternata). J. Agric. Food Chem. 52 (2004) 5391-5395
55. Heim K.E., Tagliaferro A.R., and Bobilya D.J. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J. Nutr. Biochem. 13 (2002) 572-584
56. van Elswijk D.A., Schobel U.P., Lansky E.P., Irth H., and van der Greef J. Rapid dereplication of estrogenic compounds in pomegranate (Punica granatum) using on-line biochemical detection coupled to mass spectrometry. Phytochemistry 65 (2004) 233-241
57. Bolle P., Mastrangelo S., Perrone F., and Evandri M.G. Estrogen-like effect of a Cimicifuga racemosa extract sub-fraction as assessed by in vivo, ex vivo and in vitro assays. J. Steroid Biochem. Mol. Biol. 107 (2007) 262-269
58. Onorato J., and Henion J.D. Evaluation of triterpene glycoside estrogenic activity using LC/MS and immunoaffinity extraction. Anal. Chem. 73 (2001) 4704-4710
59. Jarry H., Metten M., Spengler B., Christoffel V., and Wuttke W. In vitro effects of the Cimicifuga racemosa extract BNO 1055. Maturitas 44 (2003) 31-38
60. Bodinet C., and Freudenstein J. Influence of marketed herbal menopause preparations on MCF-7 cell proliferation. Menopause 11 (2004) 281-289
61. Gaube F., Wolfl S., Pusch L., Kroll T.C., and Hamburger M. Gene expression profiling reveals effects of Cimicifuga racemosa (black cohosh) on the estrogen receptor positive human breast cancer cell line MCF-7. BMC Pharmacol. 7 (2007) 11
62. Tong D., Schuster E., Seifert M., Czerwenka K., Leodolte S., and Zeillinger R. Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines. Breast Cancer Res. Treat. 71 (2002) 249-255
63. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., and Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138 (1997) 863-870
64. Stevens J.F., and Page J.E. Xanthohumol and related prenylflavonoids from hops and beer: to your good health!. Phytochemistry 65 (2004) 1317-1330
65. Schaefer O., Hümpel M., Fritzemeier K., Bohlman R., and Schleuning W. 8-Prenyl naringenin is a potent ERα selective phytoestrogen present in hops and beer. J. Steroid Biochem. Mol. Biol. 84 (2003) 359-360
66. Lazennec G., Bresson D., Lucas A., Chauveau C., and Vignon F. ERbeta inhibits proliferation and invasion of breast cancer cells. Endocrinology 142 (2001) 4120-4130
67. Bardin A., Hoffmann P., Boulle N., Katsaros D., Vignon F., Pujol P., and Lazennec G. Involvement of estrogen receptor beta in ovarian carcinogenesis. Cancer Res. 64 (2004) 5861-5869